David Moss, Chief Executive Officer will participate in a Dermatologic Rare Disease Panel at the Maxim Growth Summit presented by Maxim Group LLC. The Summit is being held on October 22 – 23, 2025 at the Hard Rock Hotel in New York City. The panel will be moderated by Jason McCarthy, Ph.D., Senior Managing Director, Head of Biotechnology Research. Mr. Moss will discuss Inmune Bio’s CORDStrom™, the company’s advanced cell platform for the systematic treatment of Recessive Dystrophic Epidermolysis
Wednesday, October 22, 2025 - Thursday, October 23, 2025
New York, USA
David Moss, Chief Executive Officer will participate in a Dermatologic Rare Disease Panel at the Maxim Growth Summit presented by Maxim Group LLC. The Summit is being held on October 22 – 23, 2025 at the Hard Rock Hotel in New York City. The panel will be moderated by Jason McCarthy, Ph.D., Senior Managing Director, Head of Biotechnology Research. Mr. Moss will discuss Inmune Bio’s CORDStrom™, the company’s advanced cell platform for the systematic treatment of Recessive Dystrophic Epidermolysis
Get curated B2B events, AI-powered insights, and industry trends delivered to your inbox